Pharmaceuticals, Biotechnology and Life Sciences
– Primary and secondary endpoints were met, key exploratory endpoints supported clinical benefit in Phase 3 study of omidubicel in patients with hematologic malignancies; BLA submission anticipated in fourth quarter of 2021-
— Omidubicel commercial p…
Acquisition expands Takeda’s immuno-oncology portfolio with two development candidates and Maverick’s conditionally active bispecific T-cell engagers COBRA™ platform, specifically designed to target solid tumors
Maverick’s lead candidate TAK-186 (f…
— Fourth quarter 2020 net revenues of $57.3 million; net loss of $3.6 million and diluted loss per share of $0.30 —
— Fourth quarter adjusted non-GAAP EBITDA of $17.2 million and adjusted non-GAAP diluted eps of $0.80 —
— ANI defines strategy f…
Creates Sustainable Generics Growth Engine with Approximately 25+ Launches Expected in 2021 and 2022
Expands Brand Portfolio with Addition of 505(b)(2) Pipeline and Enhances Scale of CDMO Business
Purchase Price of $163.5 Million, including $89.5…
DUBLIN–(BUSINESS WIRE)–The “Biosimilar Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change” report has been added to ResearchAndMarkets.com’s offering.
The global biosimilar monoclonal antibodies market is expected to decl…
LOS ANGELES–(BUSINESS WIRE)–$CDXC #HealthyAging–ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT).
A webc…
LOS ANGELES–(BUSINESS WIRE)–$CDXC #HealthyAging–ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT).
A webc…
LOS ANGELES–(BUSINESS WIRE)–$CDXC #HealthyAging–ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT).
A webc…
LOS ANGELES–(BUSINESS WIRE)–$CDXC #HealthyAging–ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT).
A webc…
LOS ANGELES–(BUSINESS WIRE)–$CDXC #HealthyAging–ChromaDex Corp. (NASDAQ: CDXC) is scheduled to participate in a virtual presentation at the Oppenheimer 31st Annual Healthcare Conference on Wednesday, March 17, 2021 at 3:50pm ET (12:50pm PT).
A webc…